Oh B H, Ono S, Gilpin E, Ross J
Department of Medicine, University of California San Diego, La Jolla.
Circulation. 1993 Feb;87(2):608-16. doi: 10.1161/01.cir.87.2.608.
beta-Adrenergic blockade is known to improve the survival of patients after acute myocardial infarction and to reduce myocardial infarct size in experimental coronary occlusion. However, the effects of beta-blockade on global and regional left ventricular (LV) remodeling have not been characterized after coronary occlusion with reperfusion. In rats subjected to coronary occlusion and reperfusion, we have demonstrated beneficial effects of reperfusion in sedentary rats with a hypertrophic response to exercise in the surviving outer wall of the infarcted zone, and in this study we investigated whether such remodeling is modified by beta-blockade in both sedentary and exercised rats.
Female Sprague-Dawley rats were randomized into groups at 5 days after 45 minutes of left coronary artery occlusion followed by reperfusion to produce nontransmural infarction. Animals completing the experiment included a propranolol-treated sedentary group (750 mg/l drinking water) (n = 20) and a propranolol-treated exercised group (n = 19), and these groups were compared with two groups of simultaneously randomized rats (which were also part of a separate study): an untreated sedentary group (n = 21) and an untreated exercised group (n = 20). After 3 weeks of intervention, global and regional LV morphological changes were analyzed in 78 completed experiments from midventricular transverse slices of hearts after perfusion fixation. Compared with sedentary untreated rats, propranolol-treated sedentary rats showed significantly increased LV cavity area (41.6 versus 31.5 mm2, p < 0.001) and reduced wall thicknesses in the noninfarcted (1.77 versus 1.95 mm, p < 0.01) and infarcted regions (1.29 versus 1.36 mm, p < 0.01) (two-way ANOVA). In the propranolol-treated rats, exercise further increased the LV cavity area (44.6 versus 39.1 mm2, p < 0.001), reduced the noninfarcted wall thickness (1.62 versus 1.81 mm, p < 0.01), and increased the LV dimension/wall thickness ratio in the noninfarcted region (4.7 versus 3.95 mm, p < 0.001). Whereas exercise in the reperfused group in the absence of beta-blockade significantly increased the viable subepicardial area of the infarcted zone, as reported elsewhere, propranolol treatment prevented this exercise-induced increase of subepicardial area (7.8 rest versus 7.7 mm2 exercise, NS), and there was a significant reduction of total myocardial area in the propranolol-treated exercised group compared with the untreated exercised group (p < 0.05). Corresponding trends in LV weights were not statistically significant.
These findings provide evidence for altered LV remodeling, including LV cavity dilation and reduced wall thickness, after 3 weeks of propranolol treatment in sedentary rats after coronary artery occlusion and reperfusion to produce nontransmural infarction. In addition, after 3 weeks of exercise together with propranolol treatment, morphological changes were consistent with suppression of exercise-induced myocardial hypertrophy globally and in the viable outer wall of the infarcted region, accompanied by further LV cavity dilation.
已知β-肾上腺素能阻滞剂可提高急性心肌梗死后患者的生存率,并在实验性冠状动脉闭塞时减小心肌梗死面积。然而,冠状动脉闭塞再灌注后,β-阻滞剂对左心室(LV)整体和局部重构的影响尚未明确。在经历冠状动脉闭塞和再灌注的大鼠中,我们已证明再灌注对梗死区存活外壁对运动有肥厚反应的久坐大鼠有益,在本研究中,我们调查了β-阻滞剂是否会改变久坐和运动大鼠的这种重构。
雌性Sprague-Dawley大鼠在左冠状动脉闭塞45分钟后再灌注以产生非透壁性梗死,5天后随机分组。完成实验的动物包括普萘洛尔治疗的久坐组(750mg/l饮用水)(n = 20)和普萘洛尔治疗的运动组(n = 19),将这些组与两组同时随机分组的大鼠(也是另一项单独研究的一部分)进行比较:未治疗的久坐组(n = 21)和未治疗的运动组(n = 20)。干预3周后,对灌注固定后心脏心室中部横切片的78个完整实验进行LV整体和局部形态学变化分析。与未治疗的久坐大鼠相比,普萘洛尔治疗的久坐大鼠LV腔面积显著增加(41.6对31.5mm2,p < 0.001),非梗死区(1.77对1.95mm,p < 0.01)和梗死区(1.29对1.36mm,p < 0.01)的壁厚减小(双向方差分析)。在普萘洛尔治疗的大鼠中,运动进一步增加了LV腔面积(44.6对39.1mm2,p < 0.001),减小了非梗死区壁厚(1.62对1.81mm,p < 0.01),并增加了非梗死区的LV尺寸/壁厚比(4.7对3.95mm,p < 0.001)。如其他地方所报道,在没有β-阻滞剂的情况下,再灌注组的运动显著增加了梗死区存活的心外膜下面积,而普萘洛尔治疗可防止运动引起的心外膜下面积增加(静息时7.8对运动时7.7mm2,无显著性差异),与未治疗的运动组相比,普萘洛尔治疗的运动组总心肌面积显著减少(p < 0.05)。LV重量的相应趋势无统计学意义。
这些发现为冠状动脉闭塞再灌注产生非透壁性梗死后,普萘洛尔治疗3周的久坐大鼠LV重构改变提供了证据,包括LV腔扩张和壁厚减小。此外,在运动并接受普萘洛尔治疗3周后,形态学变化与整体及梗死区存活外壁运动诱导的心肌肥大受抑制一致,同时伴有LV腔进一步扩张。